scholarly journals Revisión Bibliográfica: Degeneración Macular Relacionada con la Edad. Prevención y Tratamiento Temprano

2018 ◽  
Vol 10 (2) ◽  
pp. 145-149
Author(s):  
Katerine Leonor Ávila Heras ◽  
Yadira Karina Carrillo Mora ◽  
Sofía Nathaly Cely Jadan ◽  
Marisa Arcos
Keyword(s):  
Folic Acid ◽  
Macular Degeneration ◽  
Health Personnel ◽  
Age Related Macular Degeneration ◽  
World Health ◽  
Central Vision ◽  
Age Related ◽  
The World ◽  
Prevention And Treatment ◽  
Health Organization

Age-related macular degeneration is one of the diseases that affect the macula in people over 50 years of age, due to the existence of different multifactorial neurodegenerative changes that can lead to the loss of central vision. According to the World Health Organization there is a prevalence of 4 % worldwide; it is related of 7 % of the blindness and 3 %; Clinically it is manifested by two forms, the atrophic or dry and the exudative or wet. It has been shown that foods rich in antioxidants, folic acid and zinc help reduce this disease in early stages. This review aims to update health personnel about the prevention and treatment of age-related macular degeneration.

Neovascular Age-Related Macular Degeneration and its Association with Alzheimer’s Disease

2020 ◽  
Vol 13 (2) ◽  
pp. 102-112
Author(s):  
Zois Papadopoulos
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Macular Degeneration ◽  
Neuronal Degeneration ◽  
Developed Countries ◽  
Age Related Macular Degeneration ◽  
World Health ◽  
Treatment Modalities ◽  
Age Related ◽  
The World

: In developed countries, people of advanced age go permanently blind most often due to age-related macular degeneration, while at the global level, this disease is the third major cause of blindness, after cataract and glaucoma, according to the World Health Organisation. The number of individuals believed to suffer from the disease throughout the world has been approximated at 50 million. Age-related macular degeneration is classified as non-neovascular (dry, non-exudative) and neovascular (wet, exudative). The exudative form is less common than the non-exudative as it accounts for approximately 10 percent of the cases of the disease. However, it can be much more aggressive and could result in a rapid and severe loss of central vision. Similarly, with age-related macular degeneration, Alzheimer’s disease is a late-onset, neurodegenerative disease affecting millions of people worldwide. Both of them are associated with age and share several features, including the presence of abnormal extracellular deposits associated with neuronal degeneration, drusen, and plaques, respectively. The present review article highlights the pathogenesis, clinical features, and imaging modalities used for the diagnosis of neovascular age-related macular degeneration. A thorough overview of the effectiveness of anti-VEGF agents as well as of other treatment modalities that have either lost favour or, are rarely used, is provided in detail. Additionally, the common histologic, immunologic, and pathogenetic features of Alzheimer’s disease and age-related macular degeneration are discussed in depth.

Recomendações de equipamentos de proteção individual no combate ao COVID-19

2020 ◽  
Vol 10 (31) ◽  
pp. 87-95
Author(s):  
Nicole Maria Miyamoto Bettini ◽  
Fabiana Tomé Ramos ◽  
Priscila Masquetto Vieira de Almeida
Keyword(s):  
World Health Organization ◽  
Personal Protective Equipment ◽  
Health Professionals ◽  
Health Personnel ◽  
Healthcare Professionals ◽  
World Health ◽  
Protective Equipment ◽  
Effective Strategy ◽  
The World ◽  
Health Organization

A Organização Mundial da Saúde - OMS confirmou a circulação internacional do novo Coronavírus em janeiro de 2020, nomeando-o como COVID-19 e, declarando uma pandemia. É de extrema importância que durante a pandemia, os profissionais de saúde tenham acesso e conhecimento sobre o uso correto dos Equipamentos de Proteção Individual (EPIs) e suas indicações, tomando assim, as devidas precauções na prevenção de infecções. O presente estudo buscou identificar a padronização mundial quanto ao uso dos EPIs utilizados no atendimento a pacientes suspeitos e/ou confirmados de COVID-19 no Brasil, EUA, China, Espanha, Itália e demais países europeus. Os guidelines apresentam a padronização quanto ao uso dos EPIs utilizados no atendimento a suspeitos e/ou confirmados de COVID-19, indo ao encontro das recomendações fornecidas pela OMS. Até o momento, o uso de EPIs é sem dúvida a estratégia mais importante e eficaz para proteger os profissionais de saúde durante a assistência ao paciente com COVID-19.Descritores: Infecções por Coronavírus, Equipamento de Proteção Individual, Pessoal de Saúde, Enfermagem. Recommendations for personal protective equipment to combat COVID-19Abstract: The World Health Organization - WHO confirmed the international circulation of the new Coronavirus in January 2020, naming it as COVID-19 and declaring a pandemic. It is extremely important that during the pandemic, health professionals have access and knowledge about the correct use of Personal Protective Equipment (PPE) and its indications, thus taking appropriate precautions to prevent infections. The present study sought to identify the worldwide standardization regarding the use of PPE utilized to take care of suspected and confirmed patients with COVID-19 in Brazil, USA, China, Spain, Italy and other European countries. The guidelines present a standardization regarding the use of PPE utilized to take care of suspected and confirmed with COVID-19, in line with the recommendations provided by WHO. To date, the use of PPE is undoubtedly the most important and effective strategy to protect healthcare professionals during care for patients with COVID-19.Descriptors: Coronavirus Infections, Personal Protective Equipment, Health Personnel, Nursing. Recomendaciones para el equipo de protección personal para combatir COVID-19Resumen: La Organización Mundial de la Salud - La OMS confirmó la circulación internacional del nuevo Coronavirus en enero de 2020, nombrándolo COVID-19 y declarando una pandemia. Es extremadamente importante que durante la pandemia, los profesionales de la salud tengan acceso y conocimiento sobre el uso correcto del Equipo de Protección Personal (EPP) y sus indicaciones, tomando así las precauciones adecuadas para prevenir infecciones. El presente estudio buscó identificar la estandarización mundial con respecto al uso de EPP utilizado para atender a pacientes sospechosos y/o confirmados con COVID-19 en Brasil, Estados Unidos, China, España, Italia y otros países europeos. Las pautas presentan la estandarización con respecto al uso de EPP utilizado para cuidar COVID-19 sospechoso y/o confirmado, de acuerdo con las recomendaciones proporcionadas por la OMS. Hasta la fecha, el uso de EPP es, sin duda, la estrategia más importante y efectiva para proteger a los profesionales de la salud durante la atención de pacientes con COVID-19.Descriptores: Infecciones por Coronavirus, Equipo de Protección Personal, Personal de Salud, Enfermería.

scholarly journals Photovoltaic Restoration of Central Vision in Atrophic Age-Related Macular Degeneration

Ophthalmology ◽  
2020 ◽  
Vol 127 (8) ◽  
pp. 1097-1104 ◽  
Author(s):  
Daniel Palanker ◽  
Yannick Le Mer ◽  
Saddek Mohand-Said ◽  
Mahiul Muqit ◽  
Jose A. Sahel
Keyword(s):  
Macular Degeneration ◽  
Age Related Macular Degeneration ◽  
Central Vision ◽  
Age Related

scholarly journals World Health Organization

1947 ◽  
Vol 1 (3) ◽  
pp. 535-537 ◽  
Keyword(s):  
Public Health ◽  
Health Personnel ◽  
World Health ◽  
Wide Spread ◽  
World Health Assembly ◽  
The Third ◽  
The World ◽  
Health Organization ◽  
First World ◽  
Develop Program

Interim Commission of WHO: The third session of the Interim Commission of WHO, which began on March 30, 1947 at Geneva, closed on April 12, after assigning priority to the various health problems confronting the world. Representatives of sixteen of the eighteen member states (Liberia and the Ukrainian SSR being absent) attended the session. Results of Conference discussions indicated wide-spread agreement on such matters as 1) appointment of expert committees to develop program proposals relating to specific diseases, 2) strengthening of national health services, and 3) facilities for training public health personnel. It was hoped that a practical first year's program could be presented to the first World Health Assembly when that body convenes, probably in February, 1948.

scholarly journals Hepatitis C Worldwide and in Brazil: Silent Epidemic—Data on Disease including Incidence, Transmission, Prevention, and Treatment

2014 ◽  
Vol 2014 ◽  
pp. 1-10 ◽  
Author(s):  
Iara Fabricia Kretzer ◽  
Andrea do Livramento ◽  
Joel da Cunha ◽  
Sabrina Gonçalves ◽  
Iraci Tosin ◽  
...  
Keyword(s):  
Hepatitis C ◽  
Viral Hepatitis ◽  
Universal Access ◽  
Public Health Problem ◽  
Incidence Rates ◽  
World Health ◽  
Current Status ◽  
The World ◽  
Prevention And Treatment ◽  
Health Organization

Hepatitis C virus (HCV) is endemic worldwide and according to the World Health Organization (WHO), there are about 150 million chronic carriers worldwide. The infection is a leading cause of liver diseases like cirrhosis and hepatocellular carcinoma (HCC); thus, HCV infection constitutes a critical public health problem. There are increasing efforts worldwide in order to reduce the global impact of hepatitis C through the implementation of programmatic actions that may increase the awareness of viral hepatitis and also improve surveillance, prevention, and treatment. In Brazil, about 1,5 million people have been chronically infected with HCV. The country has a vast territory with uneven population density, and hepatitis C incidence rates are variable with the majority of cases concentrated in the most populated areas. Currently, the main priorities of Brazilian Ministry of Health's strategies for viral hepatitis management include the prevention and early diagnosis of viral hepatitis infections; strengthening of the healthcare network and lines of treatment for sexually transmitted diseases, viral hepatitis, and AIDS; improvement and development of surveillance, information, and research; and promotion of universal access to medication. This review aims to summarize the available data on hepatitis C epidemiology and current status of efforts in prevention and infection control around the world and in Brazil.

World Health Organization

1956 ◽  
Vol 10 (3) ◽  
pp. 489-491
Keyword(s):  
Health Services ◽  
World Health Organization ◽  
National Health ◽  
Health Personnel ◽  
Education And Training ◽  
Communicable Diseases ◽  
World Health ◽  
The World ◽  
Health Organization ◽  
And Training

The activities of the World Health Organization (WHO) during 1955 were surveyed in the anuual report to the World Health Assembly and to the UN of the WHO Director-General, Dr. Marcoline G. Candau. During 1955, Dr. Candau stated, substantial results had been achieved in three categories of programs: the fight against communicable diseases, the strengthening of national health services, and the raising of standards of education and training for all types of health personnel. Malaria, tuberculosis, poliomyelitis, and trachoma were among the communicable diseases towards the eradication of which WHO activities had been directed, with in many instances considerable progress. However, it had become increasingly evident that the beneficial effects of such campaigns against disease could only constitute concrete gains for public health if national health services could be effectively strengthened, and during 1955 a large part of WHO's work had continued to be devoted to that aim, in all regions but particularly in the Americas, southeast Asia and the eastern Mediterranean. In the development of national health services, particular attention had been devoted to such matters as the principle of program integration, nutrition and health education, changes in health services necessitated by the aging of populations, mental health, and environmental sanitation. In regard to education and training of health personnel, an effort had been made in the regions to increase the use of all methods which had proved their value in the past, including direct training of health personnel at all levels, provision of fellowships for study abroad, assistance to institutions and the sponsoring of international conferences, training courses and seminars.

scholarly journals Trends in snakebite mortality in India from 2000 to 2019 in a nationally representative mortality study

2020 ◽  
Author(s):  
Wilson Suraweera ◽  
David Warrell ◽  
Romulus Whitaker ◽  
Geetha R Menon ◽  
Rashmi Rodrigues ◽  
...  
Keyword(s):  
Literature Review ◽  
Rural Areas ◽  
Treatment Strategies ◽  
World Health ◽  
The World ◽  
Prevention And Treatment ◽  
Substantial Progress ◽  
Low Altitude ◽  
Nationally Representative ◽  
Health Organization

The World Health Organization call to halve global snakebite deaths by 2030 will requires substantial progress in India. We analyzed 2,833 snakebite deaths from 611,483 verbal autopsies in the nationally representative Indian Million Death Study from 2001-14, and conducted a systematic literature review from 2000-19 covering 87,590 snakebites. We estimate that India had 1.2 million snakebite deaths (average 58,000/year) from 2000-19. Nearly half occurred at ages 30-69 years and over a quarter in children <15 years. Most occurred at home in rural areas. About 70% occurred in eight higher-burden states and half during the rainy season and at low altitude. The risk of an Indian dying from snakebite before age 70 is about 1 in 250, but notably higher in some areas. More crudely, we estimate 1.11-1.77 million bites occurred in 2015, of which 70% showed symptoms of envenomation. Prevention and treatment strategies might substantially reduce snakebite mortality in India.

Sign in / Sign up

Export Citation Format

Share Document